Perle Bioscience's Unattributed Round

Perle Bioscience raised a round of funding on July 28, 2014.

Perle Bioscience is engaged in development of new pharmaceutical compositions and methods for reversing Type 1 and 2 Diabetes. Perle is setting the stage for usage of a new proprietary peptide therapy…

Articles about Perle Bioscience's Unattributed Round: